tiprankstipranks
Trending News
More News >

EMVision Appoints Carmel Monaghan as Non-Executive Director to Drive Growth

Story Highlights
EMVision Appoints Carmel Monaghan as Non-Executive Director to Drive Growth

Confident Investing Starts Here:

EMvision Medical Devices Ltd. ( (AU:EMV) ) has issued an update.

EMVision Medical Devices Limited has appointed Carmel Monaghan as an Independent Non-Executive Director. Ms. Monaghan, currently the CEO of Ramsay Healthcare Australia, brings extensive experience in healthcare leadership, corporate strategy, and marketing. Her appointment comes as EMVision is undergoing pivotal trials for regulatory clearance, positioning the company for growth and commercialization of its neurodiagnostic products. This strategic move is expected to enhance EMVision’s capabilities in addressing unmet patient needs, particularly in the areas of stroke and traumatic brain injury, which are significant global health challenges.

More about EMvision Medical Devices Ltd.

EMVision Medical Devices Limited is an innovative Australian company specializing in the development of portable, non-invasive, and affordable neurodiagnostic devices aimed at transforming the timely diagnosis and treatment of stroke and other time-sensitive medical emergencies at the point-of-care.

Average Trading Volume: 44,701

Technical Sentiment Signal: Sell

Current Market Cap: A$140.7M

For an in-depth examination of EMV stock, go to TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App